[NFBP-BlindParents] Fwd: PDPH Advisory – COVID-19 Pfizer-BioNTech Single Booster for Children between 5 to 11 years

Tue May 24 16:12:56 UTC 2022

FYI
Stacie

*Stacie Leap*
stacie.leap at gmail.com | 215.776.6741

---------- Forwarded message ---------
From: Philadelphia Department of Public Health <
health.notifications at phila.gov>
Date: Mon, May 23, 2022 at 11:00 AM
Subject: PDPH Advisory – COVID-19 Pfizer-BioNTech Single Booster for
Children between 5 to 11 years
To: stacie.leap at gmail.com <stacie.leap at gmail.com>

The Philadelphia Department of Public Health has just released a *Health
Advisory* regarding updates to COVID-19 booster dose recommendations for
children ages 5-11. It is available from https://hip.phila.gov, is appended
to this email and is attached as a PDF document. To read this attachment,
you will need the Adobe Reader software, which can be downloaded at no cost
from http://tinyurl.com/6ip.

If you have any questions or problems, please contact the Philadelphia
Department of Public Health at publichealthpreparedness at phila.gov.

To report a disease or condition to the Philadelphia Department of Public
Health, call 215-685-6748 during business hours (8:30AM to 5:00PM
Monday-Friday). If the disease or condition requires immediate notification
and it is after normal business hours, call 215-686-4514 and ask to speak
with the contact for the Division of Disease Control.

To update your contact information for the Health Alert Network or to
register to receive health alerts and newsletters from PDPH, reply directly
to this email or complete a registration form at
https://hip.phila.gov/HealthAlerts/SignUpHealthAlerts

Philadelphia Department of Public Health
*Health Advisory*
*COVID-19 Pfizer-BioNTech Single Booster for Children between 5 to 11 Years*
May 23, 2022

*Summary Points:*

   - Children between ages 5 through 11 years should receive the
   Pfizer-BioNTech single booster at least 5 months after completing the
   primary series.
   - FDA has evaluated the safety and effectiveness data and determined
   that the Pfizer-BioNTech single booster outweighs its known and potential
   risks.
   - Common side effects profiles of the Pfizer-BioNTech single booster are
   similar to the side effects from the primary series.
   - If children are eligible to receive other vaccinations, they may
   receive the COVID-19 and other vaccines during the same visit.

The CDC and FDA recommend a single booster dose of Pfizer-BioNTech COVID-19
Vaccine for children 5 through 11 years of age *at least 5 months* after
completing the primary series or the additional dose for those who are
immunocompromised. The CDC and the FDA have determined that benefits will
outweigh any known and potential risks.

Emerging data suggests that vaccine effectiveness against COVID-19 wanes
with increasing time after the second dose of vaccine in all populations
who are eligible to receive the COVID-19 vaccines.

Support for authorization is based on immune response data from a subset of
 study participants (children between ages 5 to 11 years) who received a
Pfizer-BioNTech booster dose 7 to 9 months after completing the two-dose
primary series. Antibody level against COVID-19 one month after the booster
dose was compared to the level before the booster dose and found to be
increased.

In addition to efficacy data, FDA gathered the safety information from 400
children who received a booster dose at least 5 months (ranging from 5 to 9
months) after completing a two-dose primary series. The most common side
effects were injection site pain/redness/swelling, fatigue, headache,
muscle/joint pain, chills, and fever.

Pfizer-BioNTech is the only COVID-19 vaccine authorized for children
between 5 to 11 years of age. There is no second booster dose authorized
for this age group. Children less than 5 years of age are not eligible for
any COVID-19 vaccines.

People who are 5 years and older may receive the COVID-19 vaccines and
other vaccines (i.e., a flu shot) during the same visit. If the child is
eligible to receive multiple vaccines at the same visit, each injection
should be separated by 1 inch or more.

*Resources:*

   - COVID-19 Vaccine Recommendations for Children and Teens
   <https://www.cdc.gov/coronavirus/2019-ncov/vaccines/vaccines-children-teens.html#:~:text=What%20You%20Need%20to%20Know,a%20COVID%2D19%20booster%20shot.>
   - COVID-19 Update: FDA Expands Eligibility for Pfizer-BioNTech COVID-19
   Vaccine Booster Dose to Children 5 through 11 Years
   <https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-pfizer-biontech-covid-19-vaccine-booster-dose>
   - Interim Clinical Considerations for Use of COVID-19 Vaccines Currently
   Approved or Authorized in the United States
   <https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html#recommendations>

 To stop receiving future email notifications from Philadelphia
Department Public
Health, Unsubscribe Here
<https://notifications.everbridge.net/unsubscription/email/pojUHECtuGI3GcJ3Fyi3pMOICw1qiv2UU6YJP_LfAaPzsNgG1GYzDZqhzgyfDIfeifHNh9HoRbGWW6ELO0XJMCd6IX8ZVyy2qR0DIX9QZlG7zbnGxQ6OrQI0jbU01tq6N--abV4VfT3bWJQOJhV2MV7E45EyObwxEpBHuv46Y3zsTpw1dDoP34VLn4jh5vJi573kPwp4IMf3UyBigCEw354k7N91YRW0csrqRUY93FE9H4tHWjBpc2TCRK8zhGe3JGCoC8IXanJMjuJIsG3tBpQUF0KkwVKWY1eogRYpsmXu_y7POxa6diWamtCGgTNKmjGkwAjfWb5-kPXVF3Wuxw-4UK7kGNxaOt87S49XrZl4V-XXYRuceV8988WcgUBOutGH9VNZGeDfB6Hyjdp6FenPO38fQ1zdFjNT1FrdVy1UJu2QZ_2cU5vPRLvJ37L2kmTIy6gWIB-1tQ-8glcuRGS6UldsFBnpSrJnf-OYMawWM2XR_UoZQdjr_uQccHt2NwIZP8xozGiTJbJClDfrDUjQegUiI0kdU8zFP_w3vf0=?language=en-US>.
This will unsubscribe your email address from all future email contact.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://nfbnet.org/pipermail/nfbp-blindparents_nfbnet.org/attachments/20220524/0d998b06/attachment.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: PDPH-HAN_Advisory_11_BoosterDosefor5-11_05.23.2022.pdf
Type: application/pdf
Size: 65695 bytes
Desc: not available
URL: <http://nfbnet.org/pipermail/nfbp-blindparents_nfbnet.org/attachments/20220524/0d998b06/attachment.pdf>